Role	O
of	O
endoscopy	B:C0014245
in	O
primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
:	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
(	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
)	O
and	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
(	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
)	O
Clinical	O
Guideline	I:C0282451
.	O

Role	O
of	O
endoscopy	O
in	O
primary	B:C0566602
sclerosing	I:C0566602
cholangitis	I:C0566602
:	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
(	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
)	O
and	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
(	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
)	O
Clinical	O
Guideline	I:C0282451
.	O

Role	O
of	O
endoscopy	O
in	O
primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
:	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
(	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
)	O
and	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
(	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
)	O
Clinical	O
Guideline	I:C0282451
.	O

Role	O
of	O
endoscopy	O
in	O
primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
:	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
(	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
)	O
and	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
(	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
)	O
Clinical	O
Guideline	I:C0282451
.	O

Role	O
of	O
endoscopy	O
in	O
primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
:	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
(	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
)	O
and	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
(	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
)	O
Clinical	O
Guideline	I:C0282451
.	O

Role	O
of	O
endoscopy	O
in	O
primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
:	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
(	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
)	O
and	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
(	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
)	O
Clinical	O
Guideline	I:C0282451
.	O

Role	O
of	O
endoscopy	O
in	O
primary	O
sclerosing	I:C0566602
cholangitis	I:C0566602
:	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
(	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
)	O
and	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
(	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
)	O
Clinical	B:C0282451
Guideline	I:C0282451
.	O

1	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	O
modality	O
for	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

1	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	O
modality	O
for	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

1	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	B:C0430022
modality	O
for	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

1	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	O
modality	O
for	O
PSC	B:C0566602
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

1	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	O
modality	O
for	O
PSC	O
,	O
magnetic	B:C1697842
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

1	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	O
modality	O
for	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	B:C1697842
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

1	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	O
modality	O
for	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	B:C0008310
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

1	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
that	O
,	O
as	O
the	O
primary	O
diagnostic	O
modality	O
for	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
(	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
)	O
should	O
be	O
preferred	O
over	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
(	O
endoscopic	B:C0008310
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
)	O
.	O

2	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	O
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	O
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	O
of	O
PSC	O
.	O

2	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	O
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	O
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	O
of	O
PSC	O
.	O

2	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	B:C0008310
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	O
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	O
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	O
of	O
PSC	O
.	O

2	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	B:C1697842
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	O
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	O
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	O
of	O
PSC	O
.	O

2	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	B:C0193388
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	O
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	O
of	O
PSC	O
.	O

2	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	O
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	B:C0420587
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	O
of	O
PSC	O
.	O

2	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	O
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	O
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	B:C0243095
of	O
PSC	O
.	O

2	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
can	O
be	O
considered	O
if	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
plus	O
liver	O
biopsy	I:C0193388
is	O
equivocal	O
or	O
contraindicated	O
in	O
patients	O
with	O
persisting	O
clinical	O
suspicion	O
of	O
PSC	B:C0566602
.	O

The	O
risks	O
of	O
endoscopic	B:C0008310
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
have	O
to	O
be	O
weighed	O
against	O
the	O
potential	O
benefit	O
with	O
regard	O
to	O
surveillance	O
and	O
treatment	O
recommendations	O
.	O

The	O
risks	O
of	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
have	O
to	O
be	O
weighed	O
against	O
the	O
potential	O
benefit	O
with	O
regard	O
to	O
surveillance	B:C0700325
and	O
treatment	O
recommendations	O
.	O

The	O
risks	O
of	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
have	O
to	O
be	O
weighed	O
against	O
the	O
potential	O
benefit	O
with	O
regard	O
to	O
surveillance	O
and	O
treatment	B:C0087111
recommendations	O
.	O

6	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
,	O
in	O
patients	O
with	O
an	O
established	O
diagnosis	O
of	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
should	O
be	O
considered	O
before	O
therapeutic	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
.	O

6	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
,	O
in	O
patients	O
with	O
an	O
established	O
diagnosis	O
of	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
should	O
be	O
considered	O
before	O
therapeutic	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
.	O

6	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
,	O
in	O
patients	O
with	O
an	O
established	O
diagnosis	O
of	O
PSC	B:C0566602
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
should	O
be	O
considered	O
before	O
therapeutic	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
.	O

6	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
,	O
in	O
patients	O
with	O
an	O
established	O
diagnosis	O
of	O
PSC	O
,	O
magnetic	B:C1697842
resonance	I:C1697842
cholangiography	I:C1697842
should	O
be	O
considered	O
before	O
therapeutic	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
.	O

6	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
,	O
in	O
patients	O
with	O
an	O
established	O
diagnosis	O
of	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
should	O
be	O
considered	O
before	O
therapeutic	B:C0087111
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
.	O

6	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
that	O
,	O
in	O
patients	O
with	O
an	O
established	O
diagnosis	O
of	O
PSC	O
,	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
should	O
be	O
considered	O
before	O
therapeutic	O
endoscopic	B:C0008310
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
.	O

7	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	B:C0014245
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	B:C0087111
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	B:C0005400
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	B:C0597984
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	B:C1697842
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	B:C0566602
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	B:C1457887
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	B:C0184511
following	O
endoscopic	O
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	B:C0014245
treatment	O
.	O

7	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
performing	O
endoscopic	O
treatment	O
with	O
concomitant	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
of	O
suspected	O
significant	O
strictures	O
identified	O
at	O
magnetic	O
resonance	I:C1697842
cholangiography	I:C1697842
in	O
PSC	O
patients	O
who	O
present	O
with	O
symptoms	O
likely	O
to	O
improve	O
following	O
endoscopic	O
treatment	B:C0087111
.	O

9	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
weighing	O
the	O
anticipated	O
benefits	O
of	O
biliary	O
papillotomy	I:C0085263
/	O
sphincterotomy	O
against	O
its	O
risks	O
on	O
a	O
case	O
-	O
by	O
-	O
case	O
basis	O
.	O

9	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
weighing	O
the	O
anticipated	O
benefits	O
of	O
biliary	O
papillotomy	I:C0085263
/	O
sphincterotomy	O
against	O
its	O
risks	O
on	O
a	O
case	O
-	O
by	O
-	O
case	O
basis	O
.	O

9	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
weighing	O
the	O
anticipated	O
benefits	O
of	O
biliary	B:C0085263
papillotomy	I:C0085263
/	O
sphincterotomy	O
against	O
its	O
risks	O
on	O
a	O
case	O
-	O
by	O
-	O
case	O
basis	O
.	O

9	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
weighing	O
the	O
anticipated	O
benefits	O
of	O
biliary	O
papillotomy	I:C0085263
/	O
sphincterotomy	B:C0948386
against	O
its	O
risks	O
on	O
a	O
case	O
-	O
by	O
-	O
case	O
basis	O
.	O

Biliary	B:C0085263
papillotomy	I:C0085263
/	O
sphincterotomy	O
should	O
be	O
considered	O
especially	O
after	O
difficult	O
cannulation	O
.	O

Biliary	O
papillotomy	I:C0085263
/	O
sphincterotomy	B:C0948386
should	O
be	O
considered	O
especially	O
after	O
difficult	O
cannulation	O
.	O

Biliary	O
papillotomy	I:C0085263
/	O
sphincterotomy	O
should	O
be	O
considered	O
especially	O
after	O
difficult	O
cannulation	B:C0917707
.	O

16	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
routine	O
administration	I:C0204888
of	O
prophylactic	O
antibiotics	O
before	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
in	O
patients	O
with	O
PSC	O
.	O

16	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
routine	O
administration	I:C0204888
of	O
prophylactic	O
antibiotics	O
before	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
in	O
patients	O
with	O
PSC	O
.	O

16	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
routine	B:C0204888
administration	I:C0204888
of	O
prophylactic	O
antibiotics	O
before	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
in	O
patients	O
with	O
PSC	O
.	O

16	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
routine	O
administration	I:C0204888
of	O
prophylactic	O
antibiotics	O
before	O
endoscopic	B:C0008310
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
in	O
patients	O
with	O
PSC	O
.	O

16	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
suggest	O
routine	O
administration	I:C0204888
of	O
prophylactic	O
antibiotics	O
before	O
endoscopic	O
retrograde	I:C0008310
cholangiopancreatography	I:C0008310
in	O
patients	O
with	O
PSC	B:C0566602
.	O

17	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	B:C0206698
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	B:C0206698
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	B:C0277540
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	B:C0008370
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	B:C2911645
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	B:C0229671
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	B:C0201551
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	O
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

17	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
/	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
recommend	O
that	O
cholangiocarcinoma	O
(	O
cholangiocarcinoma	O
)	O
should	O
be	O
suspected	O
in	O
any	O
patient	O
with	O
worsening	O
cholestasis	O
,	O
weight	O
loss	I:C2911645
,	O
raised	O
serum	O
CA19	O
-	I:C0201551
9	I:C0201551
,	O
and	O
/	O
or	O
new	O
or	O
progressive	O
dominant	O
stricture	B:C0597984
,	O
particularly	O
with	O
an	O
associated	O
enhancing	O
mass	O
lesion	O
.	O

19	O
European	B:C1708333
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	O
and	O
staging	O
of	O
suspected	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	B:C1708333
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	O
and	O
staging	O
of	O
suspected	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	B:C0005400
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	O
and	O
staging	O
of	O
suspected	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	B:C0220825
for	O
the	O
diagnosis	O
and	O
staging	O
of	O
suspected	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	B:C0011900
and	O
staging	O
of	O
suspected	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	O
and	O
staging	B:C0027646
of	O
suspected	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	O
and	O
staging	O
of	O
suspected	B:C0277540
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	O
and	O
staging	O
of	O
suspected	O
cholangiocarcinoma	B:C0206698
in	O
patients	O
with	O
PSC	O
.	O

19	O
European	O
Society	I:C1708333
of	I:C1708333
Gastrointestinal	I:C1708333
Endoscopy	I:C1708333
/	O
European	O
Association	I:C1708333
for	I:C1708333
the	I:C1708333
Study	I:C1708333
of	I:C1708333
the	I:C1708333
Liver	I:C1708333
recommend	O
ductal	O
sampling	O
(	O
brush	O
cytology	O
,	O
endobiliary	O
biopsies	O
)	O
as	O
part	O
of	O
the	O
initial	O
investigation	O
for	O
the	O
diagnosis	O
and	O
staging	O
of	O
suspected	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	B:C0566602
.	O

